We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Quest Diagnostics Sells OralDNA Labs to Access Genetics

By LabMedica International staff writers
Posted on 01 Jan 2013
Quest Diagnostics (Madison, NJ, USA), a provider of diagnostic information services, has sold substantially all of the assets of its OralDNA Labs salivary-diagnostics business to Access Genetics (Eden Prairie, MN, USA), a clinical laboratory with molecular diagnostics test development and information technology capabilities. More...
The terms of the transaction were not disclosed. This will allow Quest to refocus its resources on its core diagnostic information services business for physicians and hospitals.

Since 2008, Access Genetics has provided support and expertise for OralDNA-based testing services for dental professionals. As part of the transaction, OralDNA's testing services, now provided from a facility in Brentwood, TN (USA) will consolidate under Access Genetic's Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP)-certified laboratory in Eden Prairie, MN (USA).

Quest Diagnostics offers broad access to diagnostic information services through its network of laboratories and patient service centers, and provides consultation services through its medical and scientific staff.

Access Genetics provides web-based software, laboratory materials, and networked expertise to improve molecular diagnostics and patient care. The company offers comprehensive solutions to physicians including pathologists, and clinical laboratories for molecular (DNA-based) testing through a web-based Molecular Information System (TeleGene).

Related Links:
Quest Diagnostics
Access Genetics


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.